Bio Availability or Bio Equivalence study [Design Issues]

posted by jag009  – NJ, 2016-05-10 01:09 (3239 d 16:09 ago) – Posting: # 16285
Views: 8,456

Hi Ohlbe

❝ Do you think an extended release formulation can be bioequivalent to an immediate release fomulation ?


It is possible if he is talking about a ER q.d. vs IR b.i.d (or t.i.d, or q.i.d.) formulation under the same total daily dose where in some cases one might want to demonstrate bioquivalence between the two products. Example, Ultram ER is bioequivalent to Tramadol IR (given as qid)....

John

Complete thread:

UA Flag
Activity
 Admin contact
23,409 posts in 4,921 threads, 1,669 registered users;
18 visitors (0 registered, 18 guests [including 4 identified bots]).
Forum time: 16:19 CET (Europe/Vienna)

An expert is one who knows more and more
about less and less.    Nicholas Murray Butler

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5